Amgen v. Transkaryotic

Be careful what you say

In a clear caution to the pharmaceutical industry, U.S. District Court Judge William Young noted that Transkaryotic Therapies Inc. had told the FDA that its GA-EPO product and Amgen Inc.'s Epogen were equivalent in their therapeutic properties.

"A subsequent pharmaceutical manufacturer may argue to the FDA that its product is as safe or as